ID   DB-81
AC   CVCL_IR01
SY   DB81
DR   Wikidata; Q54828586
RX   Patent=US20060142219;
RX   PubMed=21818294;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 03002.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4 (Note=In complex with HIV-1 env).
CC   Miscellaneous: Registration number from personal communication of Burastero S.E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 8
//
RX   Patent=US20060142219;
RA   Lusso P., Burastero S.E.;
RT   "Pharmaceutical compositions comprising an HIV envelope protein and
RT   CD4.";
RL   Patent number US20060142219, 29-Jun-2006.
//
RX   PubMed=21818294; DOI=10.1371/journal.pone.0022081;
RA   Burastero S.E., Frigerio B., Lopalco L., Sironi F., Breda D.,
RA   Longhi R., Scarlatti G., Canevari S., Figini M., Lusso P.;
RT   "Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed
RT   against a gp120-induced epitope of CD4.";
RL   PLoS ONE 6:E22081-E22081(2011).
//